Riskpilot← Back to searchSign inGet full accessSCANORTO A/S
A/SActiveCVR 12687648Nymøllevej 50Wholesale of pharmaceutical and medical goods · NACE 4646Est. 198912 employees
Revenue 2024
DKK 12,8M
-19% vs 2023
EBITDA margin
13.9%
+31% vs 2023
Equity ratio
30.8%
Financial strength
Net profit 2024
DKK 1,7M
+14% vs 2023
| Revenue | DKK 12,8M | -19% |
| EBITDA | DKK 1,8M | +31% |
| Net profit | DKK 1,7M | +14% |
| Total assets | DKK 35,9M | +70% |
| Equity | DKK 11M | +18% |
| Employees | 12 | — |
Legal name
SCANORTO A/S
CVR number
12687648
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. januar 1989
Share capital
DKK 500.000
Employees
12 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af 2 bestyrelsesmedlemmer i forening eller af et bestyrelsesmedlem og en direktør i forening, eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive handel og produktion.
Address
Nymøllevej 50
Phone
+4539971100
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.373 | 14.702 | 13.862 | 11.709 | 17.071 | 8.587 | 8.161 | 6.444 | 6.726 | 12.741 | 14.693 | 15.819 | 12.777 |
| Staff expenses | -9.099 | -9.124 | -10.070 | -13.382 | -13.164 | -7.333 | -6.655 | -5.633 | -5.701 | -11.988 | -13.510 | -14.462 | -10.122 |
| EBITDA | 2.273 | 5.578 | 3.739 | -1.684 | 3.885 | 1.253 | 1.506 | 812 | 1.024 | 754 | 1.183 | 1.356 | 1.776 |
| Depreciation & amort. | 355 | -286 | -457 | -481 | -1.216 | -890 | -40 | -51 | -51 | -51 | -42 | -0 | -0 |
| EBIT | 1.918 | 5.292 | 3.282 | -2.165 | 2.669 | 363 | 1.466 | 760 | 973 | 702 | 1.140 | 1.356 | 1.776 |
| Net financials | 25 | -8 | -17 | -2.259 | -1.054 | -19 | -24 | -20 | -31 | -7 | -14 | 314 | 374 |
| Profit before tax | 1.943 | 5.285 | 3.265 | -4.424 | 1.615 | 345 | 1.442 | 740 | 942 | 695 | 1.127 | 1.670 | 2.149 |
| Tax | 513 | 1.313 | 809 | -959 | 374 | 80 | 330 | 177 | 209 | 163 | 266 | 215 | 494 |
| Net profit | 1.430 | 3.972 | 2.456 | -3.465 | 1.241 | 264 | 1.112 | 563 | 733 | 532 | 861 | 1.456 | 1.655 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 16.006 | 16.947 | 24.428 | 16.321 | 9.646 | 7.852 | 10.573 | 11.709 | 16.636 | 15.666 | 18.951 | 21.034 | 35.850 |
| Equity | 3.654 | 7.626 | 8.081 | 2.616 | 3.857 | 4.122 | 5.234 | 5.796 | 6.529 | 7.062 | 7.922 | 9.378 | 11.033 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 201 | 607 | 0 | 0 | 0 | 0 |
| Short-term debt | 12.240 | 9.243 | 16.028 | 13.705 | 5.789 | 3.730 | 5.322 | 5.686 | 9.464 | 8.569 | 11.003 | 11.627 | 24.775 |
| Total debt | 12.240 | 9.243 | 16.028 | 13.705 | 5.789 | 3.730 | 5.322 | 5.886 | 10.071 | 8.569 | 11.003 | 11.627 | 24.775 |
EBITDA margin
13.9%
This company
15.8%
Market median
-12% vs market
20122024
Equity ratio
30.8%
This company
38.2%
Market median
+19% vs market
20122024
Return on equity
15.0%
This company
18.4%
Market median
+18% vs market
20122024
Net profit margin
13.0%
This company
8.1%
Market median
+60% vs market
20122024
Asset turnover
0.36×
This company
1.12×
Market median
-68% vs market
20122024
Debt / equity
2.25×
This company
0.62×
Market median
-263% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SS Management | Management | 1989 | — | — |
SS Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
LL Management | Management | 2015 | — | — |
KR Management | Management | 2025 | — | — |
DG Management | Management | 2014 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 1989 | — | — | |
| Board of Directors | 1989 | — | — | |
| Board of Directors | 2000 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2024 | — | — | |
| Chairman | 2016 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2003 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2009 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
NOBEL BIOCARE DANMARK A/S | Company | 100.0% | 100.0% | 2016 |
THREE CROWN HOLDING ApS | Company | 100.0% | 100.0% | 2003 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NOBEL BIOCARE DANMARK A/S
SCANORTO A/S Board members of SCANORTO A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Steen Schierbeck | Management | 0 companies |
| Steven Schwarz | Chief Executive Officer | 0 companies |
| Lasse Lager | Management | 0 companies |
| Karel Rajchert | Management | 0 companies |
| Dennis Gert Willesen | Management | 0 companies |
| Lisa Moira Lager | Chairman | 0 companies |
| Bent Blixenkrone-Møller | Board of Directors | 0 companies |
| Peter Bisgaard | Board of Directors | 0 companies |
| Filipa Alexandra Pinto De Almeida | Board of Directors | 0 companies |
| Karel Budka | Chairman | 0 companies |
| Xavier Cherbavaz | Chairman | 0 companies |
| Maria Luisa Caggiula | Board of Directors | 0 companies |
| Hans Uwe Lassen | Board of Directors | 0 companies |
| Torben Nielsen | Chairman | 0 companies |
| Jørgen Henrik Tjørning | Board of Directors | 0 companies |